Evidence map›Paper›PMID 36270088›Full record

ArticleEuropean journal of medicinal chemistry2022

HIV-1 gp120-CXCR4 recognition probed with synthetic nanomolar affinity D-peptides containing fragments of gp120 V3 loop.

Ruohan Zhu, Qian Meng, Huijun Zhang, Ge Zhang, Lina S M Huang, Yan Xu, Robert T Schooley, Jing An, Ziwei Huang

Open access · greenAbstract read
In one paragraph

Article in European journal of medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ruohan ZhuSchool of Life Sciences, Tsinghua University, Beijing, 100084, China.
Qian MengSchool of Life Sciences, Tsinghua University, Beijing, 100084, China.
Huijun ZhangDivision of Infectious Diseases and Global Public Heath, Department of Medicine, School of Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA; Ciechanover Institute of Precision and Regenerative Medicine, School of Life and Health Sciences, Chinese University of Hong Kong, Shenzhen, 518172, China.
Ge ZhangSchool of Life Sciences, Tsinghua University, Beijing, 100084, China.
Lina S M HuangDivision of Infectious Diseases and Global Public Heath, Department of Medicine, School of Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Yan XuCiechanover Institute of Precision and Regenerative Medicine, School of Life and Health Sciences, Chinese University of Hong Kong, Shenzhen, 518172, China.
Robert T SchooleyDivision of Infectious Diseases and Global Public Heath, Department of Medicine, School of Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Jing AnDivision of Infectious Diseases and Global Public Heath, Department of Medicine, School of Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA. Electronic address: jan@health.ucsd.edu.
Ziwei HuangSchool of Life Sciences, Tsinghua University, Beijing, 100084, China; Ciechanover Institute of Precision and Regenerative Medicine, School of Life and Health Sciences, Chinese University of Hong Kong, Shenzhen, 518172, China. Electronic address: zwhny@yahoo.com.
University of California, San Diego · USTsinghua University · CNChinese University of Hong Kong, Shenzhen · CN

Funding

STRUCTURES AND INTERACTIONS OF CHEMOKINE RECEPTORSR01GM057761 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI AN, JING, HUANG, ZIWEI · 1998 to 2025
$5.6M
NIGMS NIH HHS R01 GM057761
6 · The paper itself

Abstract

The human immunodeficiency virus type 1 (HIV-1) recognizes one of its principal coreceptors, the CXC chemokine receptor 4 (CXCR4) on the host cell via the third variable loop (V3 loop) of HIV-1 envelope glycoprotein gp120 during the viral entry process. Here, we investigated the stereochemical mechanism of the molecular recognition of HIV-1 gp120 V3 loop with coreceptor CXCR4 by using peptide probes containing important fragments of the V3 loop. The tip and base/stem fragments of the V3 loop critical for V3 loop function were linked individually with the fragment derived from another CXCR4's chemokine ligand, vMIP-II to generate nanomolar affinity peptide probes of the interactions of CXCR4-V3 loop fragments. When the amino acid residues of the V3 loop fragments in these combinational peptides were changed from L-to D-configurations, the resulting peptides remarkably retained or had even enhanced recognition by CXCR4 as shown by competitive ligand-receptor binding. The ability of these peptides, regardless of the different l- or d-amino acids used, in binding CXCR4 and antagonizing CXCR4 functions was demonstrated by their blockade of calcium influx, cell migration, and CXCR4 internalization triggered by the activation of CXCR4 signaling by its endogenous ligand SDF-1α. The structural mechanisms of CXCR4 interactions with these peptides were examined with site-directed mutagenesis and molecular modeling. These results indicate that CXCR4's interface with key segments of HIV-1 gp120 V3 loop is flexible in terms of stereospecificity of ligand-receptor interaction which may have implication on understanding the viral entry mechanism and how the virus evades immune detection with V3 loop mutations and retains effective recognition of the host cell's coreceptor.

Indexed as

HIV-1HIV Envelope Protein gp120Molecular ProbesPeptide FragmentsReceptors, CXCR4Receptors, VirusVirus InternalizationChemokine CXCL12HumansLigandsReceptors, CCR5Chemokine CXCL12CXCR4 protein, humanHIV Envelope Protein gp120LigandsMolecular ProbesPeptide FragmentsReceptors, CCR5Receptors, CXCR4Receptors, VirusChemokine receptor CXCR4d-amino acidHIV-1 entryHIV-1 gp120 V3 loopMolecular recognition

Identifiers

PMID36270088
PMCPMC10150781
OpenAlexW4297537326

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.